Part D plans generally include drugs commonly used by dual-eligible enrollees : 2023 Data snapshot (United States. Department of Health and Human Services. Office of Inspector General) Dual MEDICAID MEDICARE Eligibility Formularies as Topic Government Regulation Medicare Part D Prescription Drugs Why OIG Did This Review. For dual-eligible enrollees - that is, people enrolled in both Medicare and Medicaid - access to prescription drugs is particularly important. Overall, they have very low incomes and - because they are more likely to be in poorer health than other people enrolled in Medicare - tend to use more Medicare services. Because Medicare prescription drug coverage is an important tool for ensuring access to prescription drugs, Congress mandated that OIG study whether Part D formularies cover prescription drugs commonly used by dual-eligible enrollees. What OIG Did. For this report, we determined whether the 445 unique formularies used by the 5,619 Part D plans operating in 2023 cover 195 of the 200 drugs most commonly used by dual-eligible enrollees. See the methodology for more information about how we determined the most commonly used drugs. This is OIG’s thirteenth annually mandated report examining dual-eligible enrollees’ access to drugs under Medicare Part D. Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023 United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, issuing body. Technical Report Text Illustrations 1 online resource (1 PDF file (6 pages)) nlm:nlmuid-9918716087906676-pdf 9918716087906676 http://resource.nlm.nih.gov/9918716087906676 English United States The National Library of Medicine believes this item to be in the public domain. https://creativecommons.org/publicdomain/mark/1.0